Alvaro Herrera Pérez/LinkedIn
Jun 13, 2026, 16:21
Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026
Alvaro Herrera Pérez, European MSL Lead at Agios Pharmaceuticals, shared a post on LinkedIn:
”Attending EHA 2026 at Stockholm.
Different country, same mission: collaborating with colleagues across Europe and the United States (Clinical Development and Medical Affairs) united by a common purpose: Improving outcomes for patients.
Scientific exchange, innovation, and teamwork continue to drive us forward, always with the patient at the center of everything we do.”
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 07:50Giuseppe Andò: P2Y12 Inhibition in Diabetes – A Personalized Approach
-
Sep 26, 2026, 07:36Tiffany Hall: Honored to Be Recognized for Advancing Blood Health
-
Sep 26, 2026, 07:23Jignesh Patel: Call for Papers on Safer IV Unfractionated Heparin Use
-
Sep 26, 2026, 07:13Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
-
Sep 26, 2026, 07:03Robert Tadevosyan: From Scientific Day to the Stago Factory
-
Sep 26, 2026, 07:01David McIntosh: Plasma Derived Medicines and the Global Access Gap
-
Sep 26, 2026, 06:49Heghine Khachatryan: Navigating the Complexities of Pediatric VTE
-
Sep 26, 2026, 06:44Emmanuel J Favaloro: A Century of von Willebrand Disease 2026 Virtual Issue
-
Sep 26, 2026, 05:12Saja Al-Zamili: Dual Antithrombotic Therapy After Ischemic Stroke in Atrial Fibrillation – A Meta-Analysis